CNO Financial Group, Inc. · NYSE:CNO

CNO Financial — Conseco — Q2 2009 Earnings Presentation

72 slides from CNO Financial's earnings presentation, Aug 5, 2009

  1. Slide 1: Second Quarter 2009 Financial and Operating Results

    Second Quarter 2009 Financial and Operating Results For the period ended June 30, 2009 Conseco, Inc. August 5, 2009

  2. Slide 2: Forward-Looking Statements

    Forward-Looking Statements Cautionary Statement Regarding Forward-Looking Statements. Our statements, trend analyses and other information contained in these materials relative to markets for Conseco’s products and trends in Conseco’s operations or financial results, as well as other statements, con

  3. Slide 3: Non-GAAP Measures

    Non-GAAP Measures This presentation contains the following financial measures that differ from the comparable measures under Generally Accepted Accounting Principles (GAAP): operating earnings measures; book value, excluding accumulated other comprehensive income (loss) per share; operating return m

  4. Slide 4: Q2 2009 Summary

    Q2 2009 Summary CNO ƒ Second consecutive profitable quarter • EBIT of $86.7 million, up 47% over Q2 2008 • Continued profitability in all three insurance segments • Net income of $27.6 million ƒ Core sales* of $91.8 million, down 1% from Q2 2008 ƒ Trailing four-quarter premium up 8% over a year ago

  5. Slide 5: Q2 2009 Summary

    Q2 2009 Summary CNO ƒ Net realized investment losses of $13.2 million • Total other-than-temporary impairment losses of $53.7 million • $36.6 million recorded in earnings • $17.1 million recorded in accumulated other comprehensive loss ƒ Accumulated other comprehensive loss improved by $793.6 millio

  6. Slide 6: Collected Premiums

    Collected Premiums CNO ($ millions) Collected Premiums-Trailing 4 Quarters ƒ Slight decline at Bankers Q4 2008 Q1 2009 Q2 2009 due to termination of Q2 2008 Q3 2008 $4,524.9 $4,549.3 $4,494.9 $4,275.1 $4,167.3 PFFS group quota share contracts CIG ƒ Consistent growth at Colonial Penn CP ƒ Slight decl

  7. Slide 7: Q2 2009 Summary of Results

    Q2 2009 Summary of Results CNO ($ millions, except per-share amounts) Pre-Tax After Tax EPS Bankers Life $63.3 Colonial Penn 11.0 Conseco Insurance Group 21.2 Corporate operations and interest expense (32.7) Income before net realized investment losses* $62.8 $40.8 $0.22 Net realized investment loss

  8. Slide 8: Q2 Earnings Consolidated

    Q2 Earnings CNO Consolidated ($ millions) Q2 2008 Q3 2008 Q4 2008 Q1 2009 Q2 2009 Bankers Life $34.6 $67.8 $40.0 $44.7 $63.3 Colonial Penn 8.3 6.5 6.7 5.1 11.0 Conseco Insurance Group 32.3 34.2 31.5 31.2 21.2 Corporate operations, excluding interest expense (16.2) (3.7) (0.1) (8.7) (8.8) Total EBIT*

  9. Slide 9: Operating ROE

    Operating ROE CNO Operating ROE*, Trailing 4 Quarters Operating ROE (Before Annuity Coinsurance Transaction)**, Trailing 4 Quarters Q2 2009 Q2 2009 Q1 2009 6.9% Q1 2009 6.9% Q4 2008 6.0% Q4 2008 6.0% Q3 2008 5.3% Q3 2008 5.3% 4.3% Q2 2008 4.3% 3.8% Q2 2008 1.9% *Operating return excludes net realize

  10. Slide 10: Operating EPS

    Operating EPS* CNO Q3 2008 $0.31 Q4 2008 $0.26 Q2 2009 Q1 2009 $0.22 Q2 2008 $0.17 $0.13 Seasonality of Q2 Q3 Q4 Q1 Q2 Operating EPS** 20-25% 23-28% 26-31% 17-22% 20-25% *Operating earnings per share exclude net realized investment gains (losses), valuation allowance related to deferred tax assets a

  11. Slide 11: Key Debt Covenants

    Key Debt Covenants CNO ($ millions) Q4 2008 Q1 2009 Q2 2009 Covenant Margins as of 6/30/09* Bank Covenant Debt/Capital Ratio** Covenant Maximum 30.0% 32.5% 32.5% Reduction to shareholders’ equity of approximately $807 million or Actual 28.3% 27.9% 27.0% additional debt of $389 million. Interest Cove

  12. Slide 12: Liquidity Projection For Remainder of 2009

    Liquidity Projection For Remainder of 2009 CNO ($ millions) Cash Balance 6/30/09 $78.9 Sources Dividends $25.0 Surplus Debenture Interest 17.5 Management and Investment Fees 30.0 Total Sources $72.5 Uses Interest $36.7 Debt Repayments: Senior Credit Facility 4.4 Senior Health Note 25.0 Holding Compa

  13. Slide 13: Consolidated RBC Ratio

    Consolidated RBC Ratio* CNO ƒ Q2 2009 positive impacts: • Mortgage Experience Adjustment Q2 2008 Q3 2008 Q4 2008 Q2 2009 Factor relief (29 pts) 271% 257% 255% Q1 2009 247% 230% • Statutory operating results (14 pts) ƒ Q2 2009 negative impacts: • Credit rating migration (20 pts) • Net statutory capit

  14. Slide 14: Changes in Consolidated RBC Ratio Over Last Four Quarters

    CNO 14 247% 6/30/09 RBC -38% Bond Downgrades and Impairments -9% Mortgage Experience Adjustment Factor Changes Over Last Four Quarters -59% Net Statutory Capital Losses +5% Other, Including Changes in Covariance +9% Consolidated Cash Flow Consolidated RBC Ratio – Testing Reserve Changes +2% Capital

  15. Slide 15: Capital and Risk Management Initiatives

    Capital and Risk Management Initiatives CNO ƒ Reinsure inforce business – Wilton Re – pro forma +8 pts RBC ƒ Reinsure new business (focus on Bankers) • Modified RGA agreement to increase Bankers LTC reinsurance to 70% on 2009 business ƒ Manage investment portfolio to mitigate RBC impact of ratings m

  16. Slide 16: Capital Structure

    Capital Structure CNO ($ millions) 12/31/08 3/31/09 6/30/09 Credit Facility (10/2013) $856.8 $853.4 $854.6 Revolving Credit Facility (6/2009) 55.0 55.0 0.0 6% Senior Note ($25 million/year beginning 11/2009) 125.0 125.0 125.0 3.5% Convertible Debentures (9/2010) 293.0 293.0 293.0 Unamortized Discoun

  17. Slide 17: Q2 Summary Bankers

    Q2 Summary Bankers ƒ Earnings of $63.3 million, up 83% over Q2 2008: • Higher LTC margins (+$18 million) • Higher Medicare Supplement margins (+$7 million) • Lower benefit ratio • Improved persistency • Increase in COLI surrender value (+$4 million), plus death benefit recognized (+$3 million) ƒ Con

  18. Slide 18: NAP Results Bankers

    NAP Results Bankers ($ millions) Quarterly Core NAP (Excludes PFFS) ƒ Core NAP up 6% vs Q2 2008 Q4 2008 • Strong sales of Annuities (+14%) $71.9 Q3 2008 Q2 2009 Q2 2008 Q1 2009 $61.2 $63.1 $59.8 $60.4 and Med Supp (+13%), partially offset by lower sales of LTC (-8%) and flat Life sales ƒ PFFS: • Q2

  19. Slide 19: Q2 2009 Sales and Distribution Results Bankers

    Q2 2009 Sales and Distribution Results Bankers ƒ Continued growth in agent force • Average agent count YTD 5,183, up 11% vs. first six months of 2008 ƒ Coventry’s decision to exit PFFS for 2010 not expected to disrupt distribution • During Q2 2009, announced strategic alliance with Humana to begin s

  20. Slide 20: Medicare Advantage Bankers

    Medicare Advantage Bankers ƒ As previously announced, Coventry is exiting PFFS business effective 12/31/09 • PFFS relationship terminates; affects approximately 55,000 Bankers-sold PFFS members, partially reinsured by Bankers • PDP relationship (distribution and reinsurance) remains unchanged ƒ Ente

  21. Slide 21: Annuity Sales Bankers

    Annuity Sales Bankers ($ millions) Annuities – NAP* ƒ Annuity sales up 14% vs Q2 2008 ƒ SEC designation of indexed Q4 2008 annuities as securities (Rule 151A) $24.4 not expected to significantly impact Q3 2008 Bankers total annuity sales $19.4 Q1 2009 Q2 2009 $18.2 $17.8 ƒ Majority of Bankers branch

  22. Slide 22: Annuity Surrenders Bankers

    Annuity Surrenders Bankers IA Surrenders ƒ Indexed Annuity surrenders (annualized quarterly rate) Q2 2009 higher Q2 2007 11.2% Q3 2007 10.8% Q4 2007 10.3% Q12008 Q2 2008 Q3 2008 Q4 2008 10.9% Q12009 10.5% 12.4% 9.8% 9.0% 8.6% ƒ Non-IA surrenders stable ƒ Average account value: • IAs - $41,000 • Non-

  23. Slide 23: LTC Update Bankers

    LTC Update Bankers ƒ Rate increases ahead of schedule (2008 round – policies issued prior to 2002); expect to exceed original goals • Filed $102.5 million of rate increases = 100% of original goal • As of 6/30/09: • Approvals = $70.9 million, 100% of original goal • Projected financial impact = $53.

  24. Slide 24: Q2 Earnings Bankers

    Q2 Earnings Bankers ($ millions) Q2 2008 Q3 2008 Q4 2008 Q1 2009 Q2 2009 Insurance policy income $543.4 $537.7 $531.8 $491.5 $497.6 Net investment income 135.2 138.3 155.4 142.2 163.6 Fee revenue and other income 2.1 3.1 4.2 1.4 1.6 Total revenues 680.7 679.1 691.4 635.1 662.8 Insurance policy benef

  25. Slide 25: Q2 Summary Colonial Penn

    Q2 Summary Colonial Penn ƒ Earnings of $11.0 million, up 33% over Q2 2008 • Increase primarily driven by distributions from a terminated reinsurance pool (+$3 million) ƒ Life sales of $10.6 million, down 27% from Q2 2008 • Consistent with cost reductions undertaken earlier this year as part of our c

  26. Slide 26: Q2 Earnings Colonial Penn

    Q2 Earnings Colonial Penn ($ millions) Q2 2008 Q3 2008 Q4 2008 Q1 2009 Q2 2009 Insurance policy income $47.5 $46.4 $46.5 $47.1 $52.7 Net investment income 10.1 10.1 10.2 9.8 9.8 Fee revenue and other income 0.5 0.5 0.5 0.2 0.2 Total revenues 58.1 57.0 57.2 57.1 62.7 Insurance policy benefits 35.5 33

  27. Slide 27: Q2 Summary CIG

    Q2 Summary CIG ƒ Earnings of $21.2 million, down 34% vs Q2 2008: • Lower Annuity results due to higher surrenders (-$10 million) • Lower LTC margins (-$4 million) • Lower Specified Disease margins (-$2 million) • Partially offset by higher Life margins due to favorable mortality (+$7 million) ƒ Cont

  28. Slide 28: Q2 2009 Sales and Distribution Results CIG

    Q2 2009 Sales and Distribution Results CIG ($ millions) $14.7 ƒ Specified Disease sales up 18% over Q2 2008 ƒ Worksite sales continue strong momentum, $12.4 up 13% YTD ƒ Strong recruiting results, with 126 new recruits for PMA and 502 for CIG Sales ƒ Decrease in Annuity sales, consistent with CIG’s

  29. Slide 29: Annuity Surrenders CIG

    Annuity Surrenders CIG IA Surrenders ƒ IA surrenders slightly down from (annualized quarterly rate) Q1 2009, but up significantly Q12009 44.4% Q2 2009 38.6% over 2008 due to market value adjustment feature included in Q12008 Q2 2008 18.3% Q3 2008 Q4 2008 19.4% some products Q2 2007 5.8% Q3 2007 7.7%

  30. Slide 30: Q2 Earnings CIG

    Q2 Earnings CIG ($ millions) Q2 2008 Q3 2008 Q4 2008 Q1 2009 Q2 2009 Insurance policy income $239.1 $237.7 $238.4 $244.2 $241.0 Net investment income 138.7 134.0 143.7 134.3 141.1 Fee revenue and other income 0.5 0.1 0.3 0.7 0.4 Total revenues 378.3 371.8 382.4 379.2 382.5 Insurance policy benefits

  31. Slide 31: Q2 2009 Net Realized Losses

    Q2 2009 Net Realized Losses CNO ($ millions) Amount Recognized through Accumulated Gross Other Comprehensive Amount Recognized Amounts Income through Net Income Gains on sales $83.6 - $83.6 Losses on sales (63.3) - (63.3) Losses due to recognition of other- than-temporary impairments (53.7) $(17.1)

  32. Slide 32: Q2 2009 Downgrades from Investment Grade to Below Investment Grade

    Q2 2009 Downgrades from Investment Grade to Below Investment Grade CNO ($ millions) Effect of Statutory Book Downgrades on Type Value # Issues RBC Ratio* IG Corporates $98.6 7 (0.9%) Financials 81.7 6 (0.8%) Alt-A 13.2 1 (0.1%) Prime Jumbo 176.6 8 (5.4%) Other 46.6 2 (2.3%) Total $416.7 24 (9.5%) *I

  33. Slide 33: Q2 2009 Impairment Losses

    Q2 2009 Impairment Losses CNO ($ millions) Amount Recognized through Accumulated Gross Other Comprehensive Amount Recognized Amounts Income through Net Income Below-Investment Grade Corporates $1.9 $0.0 $1.9 Financials* 17.3 0.0 17.3 Subprime 6.7 6.0 0.7 Alt-A 9.3 8.2 1.1 CMBS 1.7 1.6 0.1 Commercial

  34. Slide 34: Investment Quality: Fixed Maturities

    Investment Quality: Fixed Maturities* CNO Actively Managed Fixed Maturities by Rating at 6/30/09 (Market Value) ƒ Investment-grade bonds at 91%, unchanged from 3/31/09: • Sales of below investment- <BBB AAA grade bonds offset the 9% 14% AA negative impact of credit 6% cycle-related ratings migration

  35. Slide 35: Asset Allocation at 6/30/09

    Asset Allocation at 6/30/09* CNO ($ millions) $12,609 $11,786 MTM reflects generally tighter spreads during Q2 2009 Market Value Book Value $2,003 $2,094 $1,687 $1,669 $1,791 $1,321 $1,678 $896 $662 $653 $1,089 $318 $677 $131 $613 $655 $105 $220 er l s BS s s s S na s cy te O al an te th AB ti o M M

  36. Slide 36: Alt-A at 6/30/09

    Alt-A at 6/30/09 CNO ($ millions) Market Book % of Avg. Avg. Avg. 60+ Avg. Accum. % of Rating Value (mil.) Value (mil.) Alt-A* FICO Support Delinq. Loss Portfolio* AAA $7.0 $8.8 3.5% 691 12.8% 10.5% 0.07% 0.03% AA $45.8 $55.5 23.0% 729 8.9% 6.7% 0.41% 0.23% A $6.7 $10.0 3.3% 691 11.8% 13.3% 0.77% 0.

  37. Slide 37: Sub-Prime ABS at 6/30/09

    Sub-Prime ABS at 6/30/09 CNO ($ millions) Market Book % of Avg. Avg. Avg. 60+ % of Rating Value (mil.) Value (mil.) Subprime* FICO Support Delinq. Portfolio* AAA $15.6 $21.9 40.3% 633 34.6% 16.2% 0.08% AA $7.6 $13.7 19.6% 632 23.5% 13.4% 0.04% A $5.2 $17.2 13.4% 662 21.8% 9.9% 0.03% BBB $6.8 $13.3 1

  38. Slide 38: CMBS by Vintage at 6/30/09

    CMBS by Vintage at 6/30/09 CNO (GAAP book value - $ millions) Our CMBS exposure is heavily weighted toward securities with high ratings and seasoned vintages with relatively stronger qualitative characteristics 2009 2007 4.8% 5.3% AAA BBB AA A <BBB 2006 6.3% Pre-2004 $206.6 $34.2 $42.3 $12.0 $0.0 Pr

  39. Slide 39: CMBS at 6/30/09

    CMBS at 6/30/09 CNO ($ millions) Market Book % of Avg. Avg. 60+ Avg. Cum. % of Rating Value (mil.) Value (mil.) CMBS* Support Del. & FCR Loss Portfolio* AAA $540.2 $600.1 79.9% 27.3% 1.2% 0.41% 2.71% AA $35.7 $54.1 5.3% 26.0% 0.4% 0.09% 0.13% A $53.7 $106.4 7.9% 6.9% 0.9% 0.11% 0.27% BBB $27.6 $111.

  40. Slide 40: CMBS by Collateral Type at 6/30/09

    CMBS by Collateral Type at 6/30/09 CNO Our CMBS are backed by a diverse pool of underlying collateral – $87 billion, from more than 7,900 commercial mortgage loans Indus. Hotel 4.3% 6.0% Other 13.5% Office 28.4% Retail 33.1% Multi-Family 14.7% 40

  41. Slide 41: Commercial Mortgage Loans at 6/30/09

    Commercial Mortgage Loans at 6/30/09 CNO By Vintage By Property Type 2009 0.4% Other Indus. 0.8% 2008 14.6% 15.9% 2004 and Before 30.0% Office 38.0% 2007 19.8% Retail 2005 41.5% 11.9% 2006 22.0% Multi-Family 5.1% ƒ LTV of approximately 64% ƒ Debt Service Coverage Ratio relatively stable at underwrit

  42. Slide 42: CNO Summary

    CNO Summary CNO ƒ Second consecutive quarter of net income • Seasonality has historically produced stronger earnings in second half of year ƒ Core sales continue to improve in declining market ƒ Capital and risk management remain our top priorities • Convertible debentures due September 2010 • Conti

  43. Slide 43: Questions and Answers

    S CONSECO. Questions and Answers 43

  44. Slide 44: Appendix

    S CONSECO. Appendix 44

  45. Slide 45: Book Value Per Share

    Book Value Per Share* CNO ƒ Increase from Q1 2009 due to Q2 2008 Q2 2009 net income $21.84 Q3 2008 $20.86 Q4 2008 Q1 2009 Q2 2009 $18.41 $18.57 $18.72 *Book value excludes accumulated other comprehensive income (loss). See Appendix for corresponding GAAP measure. 45

  46. Slide 46: Net Investment Income

    Net Investment Income CNO ($ millions) General Account Investment Income ƒ Decreases in 2009 primarily Q3 2008 Q4 2008 due to increase in cash and Q2 2008 $311.9 $312.8 $319.8 Q1 2009 $308.6 Q2 2009 $308.0 short-term investment balances compared to prior periods Yield: 5.82% 5.91% 5.93% 5.67% 5.65%

  47. Slide 47: Expenses

    Expenses CNO ($ millions) Adjusted Operating Expenses* ƒ Approximately $20 million in savings Q4 2008 Q2 2009 from back-office consolidation Q2 2008 $95.8 Q3 2008 $99.2 Q1 2009 $94.4 $99.7 $94.0 realized in 2007 and 2008; remaining $5 million expected in 2009 ƒ Q4 2008 reflects increased investment

  48. Slide 48: Segment Performance Bankers

    Segment Performance Bankers ($ millions) Pre-Tax Operating Income* ƒ Earnings up 83% vs Q2 2008 Q3 2008 ƒ Earnings positively affected by: $67.8 Q2 2009 $63.3 • Higher LTC margins Q4 2008 Q1 2009 $44.7 $40.0 • Higher Life margins Q2 2008 $34.6 • Higher Med Supp margins ƒ Offset by: • FAS 133 account

  49. Slide 49: Premiums – Medicare Supplement Bankers

    Premiums – Medicare Supplement Bankers Medicare Supplement – First-Year Premiums ($ millions) Q4 2008 $23.0 Q2 2009 Q2 2008 Q3 2008 Q1 2009 $21.1 ƒ First-year premiums up 9% $19.4 $19.8 $19.7 vs Q2 2008 Med. Supp. First-Year Prems.-Tr. 4 Qtrs: $78.8 $79.3 $81.3 $81.9 $83.6 Med. Supp. Total Premiums-

  50. Slide 50: Premiums – Long-Term Care Bankers

    Premiums – Long-Term Care Bankers ($ millions) Long-Term Care – First-Year Premiums* ƒ Quarterly first-year premium declines due to new business Q3 2008 reinsurance Q2 2008 $10.6 $10.8 Q4 2008 Q1 2009 Q2 2009 (Direct) $10.3 (Direct) ƒ NAP decline attributable to three $8.6 $9.1 main factors: (Net) •

  51. Slide 51: Premiums – Life Insurance Bankers

    Premiums – Life Insurance Bankers ($ millions) Life – First-Year Premiums ƒ Fluctuations in first-year Q2 2008 $22.5 Q4 2008 Q3 2008 Q2 2009 premiums primarily reflect $19.5 $20.2 $19.4 Q1 2009 variance in sales of single- SPWL $9.4 $16.8 premium policies $7.5 $8.2 $7.8 ƒ Non-SPWL premiums down $6.2

  52. Slide 52: Premiums – Annuity Bankers

    Premiums – Annuity Bankers ($ millions) Annuity – First-Year Premiums Q4 2008 ƒ Annuity first-year premiums $410.5 up 6% over Q2 2008 Q3 2008 $322.4 Q1 2009 $301.1 Q2 2009 Q2 2008 $274.7 $260.1 First-Year Prems.-Tr. 4 Qtrs: $959.4 $1,031.3 $1,220.6 $1,294.1 $1,308.7 Total Premiums-Quarterly: $261.1

  53. Slide 53: Benefit Ratio – PDP Bankers

    Benefit Ratio* – PDP Bankers ƒ Up 2% vs Q2 2008 Q2 2009 Q2 2008 Q1 2009 ƒ Impacted by true-up to 95.2% Q3 2008 Q4 2008 95.5% 97.1% 84.6% previous quarter estimate 80.9% *We calculate benefit ratios by dividing insurance policy benefits by insurance policy income. 53

  54. Slide 54: Benefit Ratio – PFFS Individual Business Bankers

    Benefit Ratio* – PFFS Individual Business Bankers Q4 2008 ƒ Q2 2009 vs Q2 2008 Q2 2008 Q3 2008 98.1% 107.5% Q1 2009 Q2 2009 96.1% 96.2% 95.5% comparison impacted by prior- year IBNR strengthening *We calculate benefit ratios by dividing insurance policy benefits by insurance policy income. 54

  55. Slide 55: Interest-Adjusted Benefit Ratio – Long Term Care Bankers

    Interest-Adjusted Benefit Ratio* – Long Term Care Bankers ƒ Q2 2009 positively impacted by continued stabilization of incurred Q2 2008 81.4% Q3 2008 Q1 2009 claims and excess terminations Q4 2008 Q2 2009 68.1% 67.4% 68.6% 66.4% ƒ Completed Round Three re-rates on legacy block; expect $50 million ann

  56. Slide 56: Segment Performance Colonial Penn

    Segment Performance Colonial Penn ($ millions) Pre-Tax Operating Income* Q2 2009 ƒ Q2 2008 to Q2 2009 change affected by: $11.0 • $3 million reinsurance termination Q2 2008 ƒ Q1 2009 to Q2 2009 change affected by: $8.3 Q4 2008 Q3 2008 • $3 million reinsurance termination $6.5 $6.7 Q1 2009 • Favorabl

  57. Slide 57: Premiums – Life Insurance Colonial Penn

    Premiums – Life Insurance Colonial Penn ($ millions) Life – First-Year Premiums Q1 2009 Q2 2008 Q3 2008 Q4 2008 ƒ NAP: $8.9 $8.8 $8.9 $9.2 Q2 2009 $8.4 • Trailing 4 quarters relatively flat • 2009 levels consistent with capital management efforts ƒ Premium: • Recent sales growth reflected in premium

  58. Slide 58: Segment Performance CIG

    Segment Performance CIG ($ millions) Pre-Tax Operating Income* ƒ Lower Specified Disease margin due to higher incurred claims ƒ Lower Medicare Supplement margin driven by lower premium Q2 2008 Q3 2008 $34.2 Q4 2008 Q1 2009 ƒ Lower LTC margin due to higher home health $32.3 $31.5 $31.2 care costs Q2

  59. Slide 59: Premiums - Medicare Supplement CIG

    Premiums - Medicare Supplement CIG ($ millions) Medicare Supplement – First-Year Premiums ƒ NAP lower vs Q2 2008: • Continue to focus on the sale of profitable product lines, rather Q4 2008 Q2 2008 Q3 2008 than increasing overall sales $2.3 $2.1 $2.4 Q1 2009 Q2 2009 $1.9 $1.5 First-Year Prems.-Tr. 4

  60. Slide 60: Premiums – Specified Disease CIG

    Premiums – Specified Disease CIG ($ millions) Specified Disease – First-Year Premiums ƒ NAP up 18% from Q2 2008: Q4 2008 Q1 2009 Q2 2009 $11.1 Q2 2008 Q3 2008 $10.5 • Increased PMA focus on $10.2 $9.8 $9.7 Specified Disease products • Increased recruitment of Health IMOs • Momentum increasing in Wor

  61. Slide 61: Premiums – Annuity CIG

    Premiums – Annuity CIG ($ millions) Annuity – First-Year Premiums ƒ First-year collections down 40% from Q2 2009: Q2 2008 $34.4 • Discontinuance of products due Q3 2008 $25.1 to an annuity coinsurance Q4 2008 $21.2 Q1 2009 Q2 2009 $20.6 transaction $17.8 • Focus on profitable products (i.e., Specifi

  62. Slide 62: Benefit Ratio – Medicare Supplement CIG

    Benefit Ratio* – Medicare Supplement CIG Q3 2008 ƒ In line with expectations and Q2 2008 71.9% 73.0% Q1 2009 Q2 2009 71.2% Q4 2008 67.3% recent trends 62.8% ƒ Stable persistency Trailing 4 Quarter Avg.: 68.0% 69.1% 68.4% 68.8% 68.6% *We calculate benefit ratios by dividing insurance policy benefits

  63. Slide 63: Interest-Adjusted Benefit Ratio – Specified Disease CIG

    Interest-Adjusted Benefit Ratio* – Specified Disease CIG ƒ Q4 2008 included recognition of deferred ROP adjustment related Q3 2008 Q2 2009 Q2 2008 to prior periods 46.7% 48.5% Q1 2009 49.7% 42.2% ƒ Q2 2009 recognized higher Q4 2008 30.1% incurred claims Trailing 4 Quarter Avg.: 47.6% 47.4% 43.3% 41.

  64. Slide 64: Information Related to Certain Non-GAAP Financial Measures

    Information Related to Certain Non-GAAP Financial Measures The following provides additional information regarding certain non-GAAP measures used in this presentation. A non-GAAP measure is a numerical measure of a company’s performance, financial position, or cash flows that excludes or includes am

  65. Slide 65: Information Related to Certain Non-GAAP Financial Measures

    Information Related to Certain Non-GAAP Financial Measures A reconciliation of net income applicable to common stock to net operating income (and related per-share amounts) is as follows (dollars in millions, except per-share amounts): Q2 2008 Q3 2008 Q4 2008 Q1 2009 Q2 2009 Net income (loss) applic

  66. Slide 66: Information Related to Certain Non-GAAP Financial Measures

    Information Related to Certain Non-GAAP Financial Measures Book value, excluding accumulated other comprehensive income, per share This non-GAAP financial measure differs from book value per diluted share because accumulated other comprehensive income has been excluded from the book value used to de

  67. Slide 67: Information Related to Certain Non-GAAP Financial Measures

    Information Related to Certain Non-GAAP Financial Measures Operating return measures Management believes that an analysis of return before net realized gains or losses, discontinued operations and increases to our valuation allowance for deferred tax assets (“net operating income,” a non-GAAP financ

  68. Slide 68: Information Related to Certain Non-GAAP Financial Measures

    Information Related to Certain Non-GAAP Financial Measures A reconciliation of return on common equity to operating return on common equity (excluding accumulated other comprehensive income (loss) and net operating loss carryforwards) is as follows (dollars in millions, except per share amounts): Q2

  69. Slide 69: Information Related to Certain Non-GAAP Financial Measures

    Information Related to Certain Non-GAAP Financial Measures A reconciliation of pretax operating earnings (a non-GAAP financial measure) to segment operating income (loss) and consolidated net income (loss) for the six months ended June 30, 2009, is as follows (dollars in millions): CIG Bankers Colon

  70. Slide 70: Information Related to Certain Non-GAAP Financial Measures

    Information Related to Certain Non-GAAP Financial Measures A reconciliation of common shareholders’ equity, excluding accumulated other comprehensive income (loss) and net operating loss carryforwards (a non-GAAP financial measure) to common shareholders’ equity at June 30, 2009, is as follows (doll

  71. Slide 71: Information Related to Certain Non-GAAP Financial Measures

    Information Related to Certain Non-GAAP Financial Measures A reconciliation of average common shareholders’ equity, excluding accumulated other comprehensive income (loss) and net operating loss carryforwards (a non-GAAP financial measure) to average common shareholders’ equity at June 30, 2009, is

  72. Slide 72: Information Related to Certain Non-GAAP Financial Measures

    Information Related to Certain Non-GAAP Financial Measures Debt to capital ratio, excluding accumulated other comprehensive income (loss) This non-GAAP financial measure differs from the debt to capital ratio because accumulated other comprehensive income has been excluded from the value of capital

Conseco — Q2 2009 Earnings Presentation on 6ix